NEW YORK (360Dx) – Clinical Genomics and Quest Diagnostics today announced the US Food and Drug Administration cleared InSure One, a fecal immunochemical test, or FIT, designed to detect blood in stool.

Clinical Genomics manufactures InSure FIT tests, including InSure One, which Quest provides to physicians and organized provider groups, including through specialized programs with accountable care organizations across the US. The companies expect the test to be commercially available in early 2018.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.